Leiomyosarcoma MRI: Difference between revisions

Jump to navigation Jump to search
Rekha (talk | contribs)
No edit summary
Nima Nasiri (talk | contribs)
 
(12 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Leiomyosarcoma}}
{{Leiomyosarcoma}}
{{CMG}}
{{CMG}}{{AE}} {{Nnasiri}}


==Overview==
==Overview==


MRI is an imaging method using signal detection from spinning protons exposed to a magnetic field and offers superior soft tissue contrast to and better evaluation of tumor size, spread, and neurovascular involvement than CT.
[[MRI]] is usefull diagnostic tool for detecting tumor's spread to [[lymph nodes]] or internal organs in [[pelvic]] or [[abdomen]], it also has a valuable role in follow-up for the evaluation for [[tumor]] recurrence. Findings on [[MRI]] of patients with leiomyosarcoma can be heterogenous [[mass]] with irregular borders.


== MRI ==
== MRI ==
On MRI,Leiomyosarcomas commonly manifest as large infiltrating mass of heterogeneous hypo intensity on T1-weighted images,with irregular and ill-defined margins.On T2-weighted images,they usually show intermediate-to-high signal intensity, with central hyper intensity indicative of extensive necrosis.Hemorrhage is common and foci of calcification may be present.
On T1-weighted images of [[MRI]], leiomyosarcomas has the following descriptions:
* large infiltrating myometrial [[mass]] of heterogeneous hypointensity with irregular margins.
On T2-weighted images, [[tumor]]<nowiki/>s have the following features:
* Intermediate-to-high signal intensity, with central hyperintensity indicative of extensive [[necrosis]].  
* [[Hemorrhage]] is common and [[calcification]] may be present.<ref name="pmid3750612">Bretan PN, Williams RD, Hricak H (1986) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=3750612 Preoperative assessment of retroperitoneal pathology by magnetic resonance imaging. Primary leiomyosarcoma of inferior vena cava.] ''Urology'' 28 (3):251-5. PMID: [https://pubmed.gov/3750612 3750612]</ref>


==References==
==References==

Latest revision as of 14:27, 15 March 2019

Leiomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Leiomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Leiomyosarcoma MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Leiomyosarcoma MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Leiomyosarcoma MRI

CDC on Leiomyosarcoma MRI

Leiomyosarcoma MRI in the news

Blogs on Leiomyosarcoma MRI

Directions to Hospitals Treating Leiomyosarcoma

Risk calculators and risk factors for Leiomyosarcoma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]

Overview

MRI is usefull diagnostic tool for detecting tumor's spread to lymph nodes or internal organs in pelvic or abdomen, it also has a valuable role in follow-up for the evaluation for tumor recurrence. Findings on MRI of patients with leiomyosarcoma can be heterogenous mass with irregular borders.

MRI

On T1-weighted images of MRI, leiomyosarcomas has the following descriptions:

  • large infiltrating myometrial mass of heterogeneous hypointensity with irregular margins.

On T2-weighted images, tumors have the following features:

References


Template:WikiDoc Sources